2015 ASCO AM Public Sunday - ASCO
Powered by SmugMug Log In
Genitourinary (Prostate) Cancer Oral Abstract Session

Genitourinary (Prostate) Cancer Oral Abstract Session

Chicago, IL - 2015 ASCO Annual Meeting - Nicholas David James, MD, PhD, presenting abstract 5001, Docetaxel and/or zoledronic acid for hormone-naive prostate cancer: First overall survival results from STAMPEDE (NCT00268476). during Genitourinary (Prostate) Cancer Oral Abstract Session at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Sunday, May 31, 2015. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the 51st Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/David Eulitt 2015 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org

15ASCO2361.jpgAM15_Communications AM15_DailyNews